The role of contrast-enhanced computed tomography to detect renal stones.


Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 19 9 2018
medline: 31 3 2020
entrez: 19 9 2018
Statut: ppublish

Résumé

To investigate the detectability of renal stones in corticomedullary and nephrographic phases on contrast-enhanced computed tomography (CT). All consecutive patients between January 2012 and February 2016 undergoing CT of the kidneys according to our department's standard four-phase protocol and having at least one stone in the NC-phase (NCP) were included. Fifty patients with altogether 136 stones were eligible. Two radiologists in consensus evaluated the NCP from each examination and documented the number, location, and size of stones. Three abdominal radiologists blinded to the findings of the NCP reviewed independently the corticomedullary and nephrographic phases on two different occasions. They reported the number and location of stones in each kidney. For the inter-observer agreement the intra-class correlation coefficient (ICC) was estimated. The detection rate of renal stones was calculated for the three radiologists and compared between the two contrast-enhanced phases and the results were analyzed with concern to the size of the stones. The ICC was 0.86. There was no statistically significant difference between corticomedullary and nephrographic phases (p = 0.94). The detection rate for stones measuring 3-5 mm was 82-88% and 98% for stones ≥ 6 mm. The detectability of renal stones ≥ 6 mm on contrast-enhanced CT is extremely high. This means that stones with a higher risk of not passing spontaneously can be safely diagnosed.

Identifiants

pubmed: 30225609
doi: 10.1007/s00261-018-1778-7
pii: 10.1007/s00261-018-1778-7
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

652-660

Auteurs

Alice Odenrick (A)

Division of Radiology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14186, Stockholm, Sweden. alice.odenrick@gmail.com.
Department of Abdominal Radiology, Karolinska University Hospital, Huddinge, 14186, Stockholm, Sweden. alice.odenrick@gmail.com.

Nikolaos Kartalis (N)

Division of Radiology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14186, Stockholm, Sweden.
Department of Abdominal Radiology, Karolinska University Hospital, Huddinge, 14186, Stockholm, Sweden.

Nikolaos Voulgarakis (N)

Division of Radiology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14186, Stockholm, Sweden.
Department of Abdominal Radiology, Karolinska University Hospital, Huddinge, 14186, Stockholm, Sweden.

Fabian Morsbach (F)

Division of Radiology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14186, Stockholm, Sweden.
Department of Abdominal Radiology, Karolinska University Hospital, Huddinge, 14186, Stockholm, Sweden.

Louiza Loizou (L)

Division of Radiology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14186, Stockholm, Sweden.
Department of Abdominal Radiology, Karolinska University Hospital, Huddinge, 14186, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH